Document Detail

Anti-tumour effects by a trimodal combination of temozolomide, meloxicam and X-rays in cultures of human glioma cells.
MedLine Citation:
PMID:  21067299     Owner:  NLM     Status:  In-Data-Review    
Purpose: To investigate the possible cytotoxic interactions between the chemotherapeutic drug temozolomide (TMZ) and the cyclooxygenase-2 inhibitor meloxicam (MLC) or of both drugs combined with X-rays in three human glioma cell lines (D384, Hs 683 and U251). Materials and methods: Cells were exposed to TMZ (96 hours) and MLC was co-incubated during the last 24 h. Thereafter, cells were irradiated with X-rays and plated for a clonogenic assay. Total cell numbers and the numbers of surviving cells were determined to study the recovery of the cell populations (up until 19 days) following different combinations of TMZ, MLC and X-rays. Results: The combination of MLC and TMZ caused an enhanced cytotoxic effect in D384 and Hs 683. Various treatment combinations demonstrated significant radiation enhancement in all three cell lines. Long-term observations of D384 cells demonstrated that the repopulation rates of the surviving cells are far less affected by the various treatment protocols than those from the non-surviving cells. Conclusions: The present study demonstrates that a combination of TMZ and MLC resulted in a significant potentiation of their cytotoxicity in D384 and Hs683. The combination of these two drugs can also cause considerable enhancement of the radiation response in human glioma cell lines, although only D384 cells benefit from trimodal over bimodal treatment.
Krista A Van Nifterik; Jaap Van Den Berg; Ben J Slotman; Johannes Van Rijn
Related Documents :
21058189 - Induced oxidative stress and cell death in the a549 lung adenocarcinoma cell line by io...
3545359 - Cancer induction and non-stochastic effects.
8888569 - Discrepancy between the initial dna damage and cell survival after camptothecin treatme...
572979 - Radioprotection by dmso of mammalian cells exposed to x-rays and to heavy charged-parti...
16688809 - Comparison of clonogenic assay with premature chromosome condensation assay in predicti...
17043389 - Absence of radioadaptive responses in four cell-lines in vitro as determined by colony ...
3089629 - Flow cytometric determination of cell cycle parameters of v79 cells by continuous label...
18516689 - Societal interactions in ovarian cancer metastasis: a quorum-sensing hypothesis.
23452849 - Excess membrane synthesis drives a primitive mode of cell proliferation.
Publication Detail:
Type:  Journal Article     Date:  2010-11-10
Journal Detail:
Title:  International journal of radiation biology     Volume:  87     ISSN:  1362-3095     ISO Abbreviation:  Int. J. Radiat. Biol.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-02-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8809243     Medline TA:  Int J Radiat Biol     Country:  England    
Other Details:
Languages:  eng     Pagination:  192-201     Citation Subset:  IM; S    
Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Gene expression following ionising radiation: Identification of biomarkers for dose estimation and p...
Next Document:  Anti-neoplastic and immunostimulatory effects of low-dose X-ray fractions in mice.